Latest News & Features
Americas
In the second of a two-part series, Mercedes Meyer of Banner Witcoff and Brandon Phemester of Novavax delve into the real reasons why medicine costs more in the US. 12 September 2025
Americas
After four years as associate general counsel at a pharmaceutical company, the partner returns to private practice with experience across patents, trademarks, copyright and trade secret litigation. 12 September 2025
Americas
Deal resolves just one case in Regeneron’s roll-call of actions against competitors looking to launch versions of a $6bn-a-year blockbuster eye-disease treatment. 11 September 2025
Americas
In the first of a two-part series, Mercedes Meyer of Banner Witcoff and Brandon Phemester of Novavax explore how legislative, judicial, and executive policies have dramatically altered the risks for drug innovation. 10 September 2025
Careers
The firm’s medtech practice will be led by a partner with experience in digital health, medical devices, and emerging technologies, with particular expertise in advising startups. 10 September 2025
Americas
Federal oversight, funding cuts, and patent uncertainties are forcing universities, startups, and pharma companies to reassess partnership models, finds Marisa Woutersen. 9 September 2025
Careers
Wales’ first MP of ethnic minority background brings tech knowledge and expertise to the IP office, which is carrying out two pivotal consultations. 9 September 2025
Careers
The US firm has ramped up its business growth strategy with the new hires, who will represent different IP practice and industry areas. 8 September 2025
Careers
Appointment is the third ex-PTAB staffer to join, strengthens the firm’s position as a “PTAB powerhouse”. 8 September 2025
Americas
The UK pharma giant has opened a new front in its global litigation strategy involving Moderna, Pfizer, and BioNTech. 5 September 2025